Argos Therapeutics Employee Directory
BiotechnologyNorth Carolina, United States51-200 Employees
Argos Therapeutics is a mid-sized biotechnology company based in Durham, North Carolina, focused on developing and delivering personalized immunotherapies for cancer and infectious diseases. It harnesses its Arcelis platform to create individualized treatments that aim to address patient-specific disease biology. Its lead candidate, rocapuldencel-T, is in a pivotal Phase 3 trial for metastatic renal cell carcinoma and is also being evaluated in Phase 2 investigator-initiated studies as neoadjuvant therapy for RCC and for non-small cell lung cancer. Argos is developing a second Arcelis-based product, AGS-004, for HIV and it is currently evaluated in an investigator-initiated Phase 2 trial aimed at HIV eradication in adults. The company operates within the biotechnology research sector and maintains a mid-sized team.
1-888-653-2347 
support@leadiq.com 
